EUVIMEDEUVIMED entdecken
Crossref

Initial evaluation of 4-palmitoyloxy butyrate in whole blood as potential biomarker after γ-hydroxybutyric acid intake

Jennifer Liut iD, Burkhard Madea, Dirk Meißner, Arne Lützen, Sirous Javidi, Cornelius Hess, Michael Krämer

Journal of Analytical Toxicology · 2025

DOI: 10.1093/jat/bkae095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2025. Verfasst von Jennifer Liut und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine, Forensic Toxicology, University of Bonn, Bonn 53111, Germany. Hauptthemen laut MEDLINE: Substance Abuse Detection, Hydroxybutyrates, Sodium Oxybate. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The problem of finding a suitable biomarker to widen the detection window of γ-hydroxybutyric acid (GHB) intake remains a challenge in forensic toxicology. Based on previously published results, the present study deals with the evaluation of a fatty acid ester of GHB (4-palmitoyloxy butyrate [GHB-Pal]) in whole blood as a potential biomarker to extend the detection window of GHB use, e.g. in drug-facilitated sexual assaults. A liquid chromatography–mass spectrometry (LC–MS–MS) method for the quantification of GHB-Pal in whole blood was validated. Whole blood samples were collected from subjects involed in police roadside controls (n = 113) and from narcolepsy patients (n = 10) after the controlled administration of Xyrem® (sodium oxybate). Both sample collectives were previously tested for GHB using two different methods: ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS–MS) and gas chromatography–mass spectrometry (GC–MS). In samples from routine police casework, GHB-Pal was detected in 67 out of 113 analysed GHB-positive samples with a mean concentration of 0.8 ng/mL ± 0.5 ng/mL (standard deviation). Among samples that were tested positive for both compounds, no linear correlation was observed between GHB and GHB-Pal concentrations (r = 0.508). In contrast, GHB-Pal was not detected in any of the blood samples analysed from the patients. The absence of GHB and GHB-Pal in the patient cohort may be attributed to the time interval between dose intake and blood collection (approximately 3 and 6 h), during which GHB was eliminated from the body. Furthermore, GHB-Pal was only detectable at a GHB concentration of at least 16 µg/mL, which indicates that endogenous concentrations or low GHB doses may not be sufficient for GHB-Pal formation. Due to missing correlation between both compounds and the lack of GHB-Pal detection several hours after GHB administration, it can be assumed that GHB-Pal in blood is not a suitable biomarker to widen the detection window of GHB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse DetectionHydroxybutyratesSodium OxybateHumansBiomarkersTandem Mass SpectrometryMaleFemaleNarcolepsyAdultGas Chromatography-Mass SpectrometryForensic ToxicologyChromatography, Liquid

Substanzen

BiomarkersHydroxybutyratesSodium Oxybate4-hydroxybutyric acid

Autor:innen und Institutionen

  • Institute of Forensic Medicine, Forensic Toxicology, University of Bonn, Bonn 53111, Germany.
  • Kekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn 53121, Germany.
  • Hephata Hospital Schwalmstadt-Centre for Sleep Medicine, Hephata Hessian Diaconal Centre e.V., Schwalmstadt 34613, Germany.
  • Division of Clinical and Forensic Toxicology, MVZ Dr. Stein and Colleagues, Mönchengladbach 41169, Germany.

ORCID-Profile: Jennifer Liut

Zitieren

APA

Liut, J., Madea, B., Meißner, D., Lützen, A., Javidi, S., Hess, C., & Krämer, M. (2025). Initial evaluation of 4-palmitoyloxy butyrate in whole blood as potential biomarker after γ-hydroxybutyric acid intake. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae095

Vancouver

Liut J, Madea B, Meißner D, Lützen A, Javidi S, Hess C, et al. Initial evaluation of 4-palmitoyloxy butyrate in whole blood as potential biomarker after γ-hydroxybutyric acid intake. Journal of Analytical Toxicology. 2025. doi:10.1093/jat/bkae095

BibTeX
@article{Liut2025,
  author = {Liut, Jennifer and Madea, Burkhard and Meißner, Dirk and Lützen, Arne and Javidi, Sirous and Hess, Cornelius and Krämer, Michael},
  title = {Initial evaluation of 4-palmitoyloxy butyrate in whole blood as potential biomarker after γ-hydroxybutyric acid intake},
  journal = {Journal of Analytical Toxicology},
  year = {2025},
  doi = {10.1093/jat/bkae095}
}
Kostenlos starten →